Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3050684rdf:typepubmed:Citationlld:pubmed
pubmed-article:3050684lifeskim:mentionsumls-concept:C0017601lld:lifeskim
pubmed-article:3050684lifeskim:mentionsumls-concept:C0521141lld:lifeskim
pubmed-article:3050684lifeskim:mentionsumls-concept:C0181899lld:lifeskim
pubmed-article:3050684lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:3050684lifeskim:mentionsumls-concept:C0022592lld:lifeskim
pubmed-article:3050684pubmed:issue3lld:pubmed
pubmed-article:3050684pubmed:dateCreated1988-11-3lld:pubmed
pubmed-article:3050684pubmed:abstractTextSeventeen patients (17 eyes) underwent implantation of a single plate Molteno implant for medically uncontrollable intraocular pressures after penetrating keratoplasty. Most of the eyes had extensive peripheral anterior synechiae, and 16 of 17 (94%) were pseudophakic or aphakic following keratoplasty. Other glaucoma procedures had been performed previously on 13 eyes: argon laser trabeculoplasty (one eye), trabeculectomy (seven eyes), transpupillary argon laser cyclophotocoagulation (three eyes), and cyclocryotherapy (three eyes). Follow-up ranged from 5 to 28 months (mean, 13 months). Three eyes underwent repeat Molteno implantation when intraocular pressure (IOP) was not satisfactorily reduced after the first procedure. Considering one eye with chronic hypotony as a failure, 12 of 17 eyes (71%) had IOPs of less than 21 mmHg at the time of the three most recent postoperative examinations after a single Molteno implant. Repeat implants in three eyes increased the number of eyes with IOPs of less than 21 mmHg to 14 (82%). Corneal allograft rejection after Molteno implantation occurred in seven eyes; two of these were successfully reversed with corticosteroid therapy. Three of the five eyes with irreversible graft rejection were regrafted, and two of these grafts have remained clear. Including the regrafted eyes, 13 eyes had clear grafts and controlled IOPs at the most recent postoperative examination. The Molteno implant may prove useful in the management of medically uncontrollable glaucoma following penetrating keratoplasty; however, there appears to be a substantial risk of postoperative graft rejection.lld:pubmed
pubmed-article:3050684pubmed:languageenglld:pubmed
pubmed-article:3050684pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3050684pubmed:citationSubsetIMlld:pubmed
pubmed-article:3050684pubmed:statusMEDLINElld:pubmed
pubmed-article:3050684pubmed:monthMarlld:pubmed
pubmed-article:3050684pubmed:issn0161-6420lld:pubmed
pubmed-article:3050684pubmed:authorpubmed-author:SmithR ERElld:pubmed
pubmed-article:3050684pubmed:authorpubmed-author:McDonnellP...lld:pubmed
pubmed-article:3050684pubmed:authorpubmed-author:SchanzlinD...lld:pubmed
pubmed-article:3050684pubmed:authorpubmed-author:MincklerDDlld:pubmed
pubmed-article:3050684pubmed:authorpubmed-author:RobinJ BJBlld:pubmed
pubmed-article:3050684pubmed:authorpubmed-author:BaerveldtGGlld:pubmed
pubmed-article:3050684pubmed:authorpubmed-author:HeuerDDlld:pubmed
pubmed-article:3050684pubmed:issnTypePrintlld:pubmed
pubmed-article:3050684pubmed:volume95lld:pubmed
pubmed-article:3050684pubmed:ownerNLMlld:pubmed
pubmed-article:3050684pubmed:authorsCompleteYlld:pubmed
pubmed-article:3050684pubmed:pagination364-9lld:pubmed
pubmed-article:3050684pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:meshHeadingpubmed-meshheading:3050684-...lld:pubmed
pubmed-article:3050684pubmed:year1988lld:pubmed
pubmed-article:3050684pubmed:articleTitleMolteno implant for control of glaucoma in eyes after penetrating keratoplasty.lld:pubmed
pubmed-article:3050684pubmed:affiliationEstelle Doheny Eye Foundation, Los Angeles, CA 90033.lld:pubmed
pubmed-article:3050684pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3050684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3050684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3050684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3050684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3050684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3050684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3050684lld:pubmed